Luigi Fattore
ScholarGPS® ID: 23040476776659
Affiliation History
Field
Life Sciences
Discipline
Molecular and Cell Biology
Metrics Summary
Publication Count
28
Predicted Citations
1,059
Predicted h-index
21
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors (journal article) Cell Death & Disease, volume 15, issue 3 (2024). |
The new world of RNA diagnostics and therapeutics (journal article) Journal of Experimental & Clinical Cancer Research, volume 42, issue 1 (2023). |
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma (journal article) Frontiers in Oncology, volume 11 (2021). |
Drug tolerance to target therapy in melanoma revealed at single cell level: What next? (journal article) Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, volume 1874, issue 2, pages 188440- (2020). |
Cell Communication and Signaling, volume 18, issue 1 (2020). |
Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma (journal article) Cancers, volume 12, issue 11, pages 3368- (2020). |
International Journal of Molecular Sciences, volume 21, issue 6, pages 1930- (2020). |
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions (journal article) Journal of Cellular Physiology, volume 235, issue 3, pages 1877-1887 (2020). |
microRNA-378a-5p iS a novel positive regulator of melanoma progression (journal article) Oncogenesis, volume 9, issue 2 (2020). |
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma (journal article) Cell Death & Disease, volume 10, issue 11 (2019). |
Cancers, volume 11, issue 10, pages 1425- (2019). |
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma (journal article) Cell Death & Differentiation, volume 26, issue 7, pages 1267-1282 (2019). |
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma (journal article) Expert Opinion on Therapeutic Targets, volume 23, issue 1, pages 53-68 (2019). |
c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells (journal article) International Journal of Molecular Sciences, volume 20, issue 2, pages 320- (2019). |
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma (journal article) Journal of Experimental & Clinical Cancer Research, volume 37, issue 1 (2018). |
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma (journal article) Cytokine & Growth Factor Reviews, volume 36 (2017). |
Selective targeting of point-mutated KRAS through artificial microRNAs (journal article) Proceedings of the National Academy of Sciences, volume 114, issue 21 (2017). |
MicroRNAs in melanoma development and resistance to target therapy (journal article) Oncotarget (2017). |
Proceedings of the National Academy of Sciences, volume 113, issue 34 (2016). |
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors (journal article) Journal of Translational Medicine, volume 13, issue S1 (2015). |